Dear Colleagues,
Dear Friends,

The international symposium ACUTE LEUKEMIAS XVIII (ISALXVIII) is taking place in Munich in-person and online from Sunday, March 19 until Wednesday, March 22, 2023.

The scientific program will start on Sunday, March 19, 2023, with the focus on basic research while the following days will concentrate on translational research and clinical studies. You are cordially invited to use this forum to become updated on recent developments in the complex field of leukemia research and therapy.

The Symposium will focus on the following key areas:

MS I: Epigenetic Changes in Acute Leukemias
MS II: Clonal Evolution and Leukemic Stem Cells
MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis
MS IV: Novel Approaches and Targeted Therapies in AML
MS VI: Risk adapted Therapy of AML
MS VII: Biology and Treatment of APL
MS VIII: Relevance of MRD in Acute Leukemias
MS X: Immunotherapy for Acute Leukemias
MS XI: ALL: Biology and Treatment Strategies

Satellite Symposia and Meet-the-Expert Sessions will deliver further chances to discuss advances and perspectives of basic science and treatment strategies.

The two free contributions sessions - MS V: Poster session and MS IX: Best of Free Contributions Session - will additionally deliver the possibility to all those who want to present their own research data and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias beside the main sessions.

We look forward to welcoming you in-person in Munich March 2023

Yours

Wolfgang Hiddemann
Chairman ISALXVIII March 19-22, 2023